Sonnet BioTherapeutics Holdings Inc Ordinary Shares (NASDAQ:SONN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SONN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SONN

  • Market Cap$41.740m
  • SymbolNASDAQ:SONN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS83548R1059

Company Profile

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Latest SONN news

Currently there for this company. Visit our news hub for other news .